Dov Hershkovitz

3.7k total citations
95 papers, 2.2k citations indexed

About

Dov Hershkovitz is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Dov Hershkovitz has authored 95 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Oncology, 21 papers in Molecular Biology and 20 papers in Cancer Research. Recurrent topics in Dov Hershkovitz's work include Cancer Genomics and Diagnostics (18 papers), Genetic factors in colorectal cancer (12 papers) and Lung Cancer Treatments and Mutations (8 papers). Dov Hershkovitz is often cited by papers focused on Cancer Genomics and Diagnostics (18 papers), Genetic factors in colorectal cancer (12 papers) and Lung Cancer Treatments and Mutations (8 papers). Dov Hershkovitz collaborates with scholars based in Israel, United States and Germany. Dov Hershkovitz's co-authors include Eli Sprecher, Edmond Sabo, Avi Schroeder, Assaf Zinger, Mor Goldfeder, Richard N. Bergman, Ofer Ben‐Izhak, Einat Even‐Sapir, Eyal Mishani and Janna Shainsky‐Roitman and has published in prestigious journals such as Nature Communications, The Journal of Experimental Medicine and ACS Nano.

In The Last Decade

Dov Hershkovitz

91 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dov Hershkovitz Israel 26 647 587 428 335 272 95 2.2k
Guoliang Wang China 23 748 1.2× 353 0.6× 432 1.0× 198 0.6× 226 0.8× 149 2.0k
Feng Mao China 27 1.1k 1.8× 632 1.1× 355 0.8× 424 1.3× 351 1.3× 159 2.6k
Yasuo Iwadate Japan 27 852 1.3× 573 1.0× 613 1.4× 418 1.2× 146 0.5× 156 2.6k
Ruslan Hlushchuk Switzerland 31 1.5k 2.3× 485 0.8× 493 1.2× 537 1.6× 534 2.0× 84 3.1k
Zu‐Xi Yu United States 32 1.1k 1.6× 385 0.7× 385 0.9× 227 0.7× 479 1.8× 93 3.0k
Satoshi Takagi Japan 28 838 1.3× 582 1.0× 624 1.5× 265 0.8× 502 1.8× 151 3.2k
Brian W. Simons United States 26 1.1k 1.7× 609 1.0× 728 1.7× 413 1.2× 219 0.8× 70 2.5k
Clark C. Chen United States 29 1.1k 1.7× 581 1.0× 572 1.3× 450 1.3× 147 0.5× 131 2.7k
Keith D. Hunter United Kingdom 29 1.1k 1.8× 861 1.5× 266 0.6× 475 1.4× 528 1.9× 157 3.2k
Kazuhiro Yoshikawa Japan 26 1.0k 1.6× 660 1.1× 455 1.1× 304 0.9× 219 0.8× 159 2.5k

Countries citing papers authored by Dov Hershkovitz

Since Specialization
Citations

This map shows the geographic impact of Dov Hershkovitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dov Hershkovitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dov Hershkovitz more than expected).

Fields of papers citing papers by Dov Hershkovitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dov Hershkovitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dov Hershkovitz. The network helps show where Dov Hershkovitz may publish in the future.

Co-authorship network of co-authors of Dov Hershkovitz

This figure shows the co-authorship network connecting the top 25 collaborators of Dov Hershkovitz. A scholar is included among the top collaborators of Dov Hershkovitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dov Hershkovitz. Dov Hershkovitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gitstein, Gilad, et al.. (2024). Automatic analysis of nuclear features reveals a non-tumoral predictor of tumor grade in bladder cancer. Diagnostic Pathology. 19(1). 75–75.
2.
Perry, Chava, et al.. (2023). Image-Based Deep Learning Detection of High-Grade B-Cell Lymphomas Directly from Hematoxylin and Eosin Images. Cancers. 15(21). 5205–5205. 10 indexed citations
3.
Hershkovitz, Dov, et al.. (2023). Perineural invasion detection in pancreatic ductal adenocarcinoma using artificial intelligence. Scientific Reports. 13(1). 13628–13628. 9 indexed citations
4.
Hasson, Shira Peleg, Dov Hershkovitz, Yuval Raviv, et al.. (2022). Implementation of Comprehensive Genomic Profiling in Ovarian Cancer Patients: A Retrospective Analysis. Cancers. 15(1). 218–218.
5.
Hershkovitz, Dov, et al.. (2022). Digital PCR-Based Method for Detecting CDKN2A Loss in Brain Tumours. Molecular Diagnosis & Therapy. 26(6). 689–698. 5 indexed citations
6.
Kaduri, Maya, Maria Poley, Patricia Mora‐Raimundo, et al.. (2021). Targeting neurons in the tumor microenvironment with bupivacaine nanoparticles reduces breast cancer progression and metastases. Science Advances. 7(41). eabj5435–eabj5435. 37 indexed citations
7.
Golan, Tamar, Roma Parikh, Etai Jacob, et al.. (2019). Adipocytes sensitize melanoma cells to environmental TGF-β cues by repressing the expression of miR-211. Science Signaling. 12(591). 23 indexed citations
8.
Zinger, Assaf, Omer Adir, Assaf Simon, et al.. (2018). Proteolytic Nanoparticles Replace a Surgical Blade by Controllably Remodeling the Oral Connective Tissue. ACS Nano. 12(2). 1482–1490. 20 indexed citations
9.
Bublik, Débora Rosa, Sarit Aviel‐Ronen, Keren Levanon, et al.. (2018). PAX8 activates a p53-p21-dependent pro-proliferative effect in high grade serous ovarian carcinoma. Oncogene. 37(17). 2213–2224. 35 indexed citations
10.
Zinger, Assaf, Zvi Yaari, Mor Goldfeder, et al.. (2017). Nanoparticles target early-stage breast cancer metastasisin vivo. Nanotechnology. 28(43). 43LT01–43LT01. 32 indexed citations
11.
Blumenthal, Deborah T., Andrew A. Kanner, Orna Aizenstein, et al.. (2017). Surgery for Recurrent High-Grade Glioma After Treatment with Bevacizumab. World Neurosurgery. 110. e727–e737. 11 indexed citations
12.
Keller, Baerbel, Irina Zaidman, O. Sascha Yousefi, et al.. (2016). Early onset combined immunodeficiency and autoimmunity in patients with loss-of-function mutation in LAT. The Journal of Experimental Medicine. 213(7). 1185–1199. 44 indexed citations
13.
Kurolap, Alina, Tova Hershkovitz, Adi Mory, et al.. (2016). Loss of Glycine Transporter 1 Causes a Subtype of Glycine Encephalopathy with Arthrogryposis and Mildly Elevated Cerebrospinal Fluid Glycine. The American Journal of Human Genetics. 99(5). 1172–1180. 25 indexed citations
14.
Alishekevitz, Dror, Svetlana Gingis‐Velitski, Orit Kaidar‐Person, et al.. (2016). Macrophage-Induced Lymphangiogenesis and Metastasis following Paclitaxel Chemotherapy Is Regulated by VEGFR3. Cell Reports. 17(5). 1344–1356. 91 indexed citations
15.
16.
Bergman, Richard N., Rachel Bar‐Shalom, Einav Simon, et al.. (2014). A Deep Penetrating Facial Congenital Melanocytic Tumor With Bone Involvement and Ipsilateral Eye Blindness. American Journal of Dermatopathology. 37(1). e5–e11. 1 indexed citations
17.
Avitan‐Hersh, Emily, Margarita Indelman, Vardit Gepstein, et al.. (2013). Postzygotic HRAS Mutation Causing Both Keratinocytic Epidermal Nevus and Thymoma and Associated With Bone Dysplasia and Hypophosphatemia Due to Elevated FGF23. The Journal of Clinical Endocrinology & Metabolism. 99(1). E132–E136. 23 indexed citations
18.
Ben‐Ishay, Offir, et al.. (2011). Rectal duplication cyst in adults treated with transanal endoscopic microsurgery. Techniques in Coloproctology. 15(4). 469–471. 18 indexed citations
19.
Bergman, Richard N., et al.. (2009). Disadhesion of epidermal keratinocytes: A histologic clue to palmoplantar keratodermas caused by DSG1 mutations. Journal of the American Academy of Dermatology. 62(1). 107–113. 19 indexed citations
20.
Hershkovitz, Dov, Hannah Mandel, Akemi Ishida‐Yamamoto, et al.. (2008). Defective Lamellar Granule Secretion in Arthrogryposis, Renal Dysfunction, and Cholestasis Syndrome Caused by a Mutation in VPS33B. Archives of Dermatology. 144(3). 334–40. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Guoliang Wang Breakdown of academic impact, for papers by Feng Mao Breakdown of academic impact, for papers by Yasuo Iwadate Breakdown of academic impact, for papers by Ruslan Hlushchuk Breakdown of academic impact, for papers by Zu‐Xi Yu Breakdown of academic impact, for papers by Satoshi Takagi Breakdown of academic impact, for papers by Brian W. Simons Breakdown of academic impact, for papers by Clark C. Chen Breakdown of academic impact, for papers by Keith D. Hunter Breakdown of academic impact, for papers by Kazuhiro Yoshikawa
Rankless by CCL
2026